Analysts expect SAB Biotherapeutics, Inc. to report revenue of 0.00 for Q2 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q1 26, came in at 0.00.
| Metric | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 300,000.00 | 0.00 | 100,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | |||||||||||
| High Estimate | 0.00 | 135,621.51 | 121,125.18 | 130,854.42 | 129,401.66 | 101,954.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -26,639.52 | -41,019.75 | -9,358.21 | 1.95 M | |||||||||||
| Low Estimate | 0.00 | 114,348.09 | 110,783.22 | 110,101.82 | 111,497.10 | 93,360.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -28,377.84 | -46,746.03 | -10,585.75 | 1.81 M | |||||||||||
| Consensus Estimate | 0.00 | 124,984.80 | 115,954.20 | 120,478.12 | 120,449.38 | 97,657.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -27,508.68 | -43,882.89 | -9,971.98 | 1.88 M |
Analysts expect SAB Biotherapeutics, Inc. to report earnings per share of -0.30 for Q2 26, against a range of -0.32 to -0.28. The most recent reported quarter, Q1 26, came in at -0.35, a 75.0% miss against the -0.20 consensus.
| Metric | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.79 | -1.12 | -1.23 | -0.56 | -1.09 | -0.21 | -0.27 | -0.35 | - | - | - | - | - | - | - | - | |||||||||||
| High Estimate | -1.06 | -1.10 | -1.16 | -0.91 | -0.69 | -0.45 | -0.21 | -0.18 | -0.28 | -0.25 | -0.23 | -0.19 | -0.25 | -0.08 | -0.08 | -0.17 | |||||||||||
| Low Estimate | -1.28 | -1.24 | -1.28 | -1.09 | -0.83 | -0.51 | -0.23 | -0.22 | -0.32 | -0.27 | -0.27 | -0.21 | -0.29 | -0.08 | -0.08 | -0.19 | |||||||||||
| Consensus Estimate | -1.17 | -1.17 | -1.22 | -1.00 | -0.76 | -0.48 | -0.22 | -0.20 | -0.30 | -0.26 | -0.25 | -0.20 | -0.27 | -0.08 | -0.08 | -0.18 |